. Author manuscript; available in PMC: 2015 Jun 5.

Published in final edited form as: Gynecol Oncol Rep. 2015 Apr 1;12:37–40. doi: 10.1016/j.gore.2015.02.007

Table 2.

Analysis of Covariance Models assessing factors associated with cervical cancer prevention knowledge score at third survey administration among high risk women. Both models controlled for study site.

	Model for women completing all 3 survey administrations N=974	Model for women who completed the third survey administration N=1968
Adjusted R²	0.35	0.10
F-Value	46.98^***	18.2^***
Predictor variables
Intercept	8.94 (7.47, 10.40)^***	15.69 (14.60, 16.79)
Total baseline score (1^st)	0.27 (0.22, 0.33)^***
Total follow-up score (2^nd)	0.28 (0.22, 0.34)^***
Recruitment cohort (vs 3^rd cohort)
Cohort 1		1.12 (0.36, 1.88)^**
Cohort 2		0.96 (0.20, 1.71)^*
HIV seropositive (vs negative)	−0.18 (−0.75, 0.39)	0.52 (−0.003, 1.03)
Age less than 50 (vs 50+ yrs)		0.71 (0.17, 1.24)^**
Ethnicity (vs White NH)
Non-Hispanic African American		−1.76 (−2.52, −1.00)^***
Hispanic		−1.50 (−2.36, −0.64)^***
Other		−1.61 (−2.95, −0.27)^**
Education (vs College)
Less than High school	−0.88 (−1.57, −0.18)^*	−2.61 (−3.20, −2.03)^***
Completed High school	−0.10 (−0.76, 0.57)	−0.96 (−1.55, −0.37)^***
Income <$18,000 (vs >$18,000)	−0.82 (−1.41, −0.24)^**	−1.27 (−1.79, −0.75)^***
Drug use (vs never)
Former user		0.85 (0.30, 1.39)^**
Current user		0.61 (−0.01, 1.22)

p <= 0.05;

^**

p <= 0.01;

^***

p <= 0.001